These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27539608)

  • 41. Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.
    Kwak HB; Lee BK; Oh J; Yeon JT; Choi SW; Cho HJ; Lee MS; Kim JJ; Bae JM; Kim SH; Kim HS
    Bone; 2010 Mar; 46(3):724-31. PubMed ID: 19900598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H; Zhao L; Cao H; Chen A; Xiao J
    FASEB J; 2015 Mar; 29(3):1092-101. PubMed ID: 25466887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
    Kim HJ; Yoon KA; Lee MK; Kim SH; Lee IK; Kim SY
    Life Sci; 2012 Nov; 91(19-20):928-34. PubMed ID: 23000100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
    Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
    Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
    Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
    Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect.
    Jung Koo H; Sohn EH; Kim YJ; Jang SA; Namkoong S; Chan Kang S
    J Ethnopharmacol; 2014 Feb; 151(2):951-9. PubMed ID: 24333364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K
    Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice.
    Kim JY; Cheon YH; Oh HM; Rho MC; Erkhembaatar M; Kim MS; Lee CH; Kim JJ; Choi MK; Yoon KH; Lee MS; Oh J
    Bone; 2014 Mar; 60():104-11. PubMed ID: 24361669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways.
    Ma X; Liu Y; Zhang Y; Yu X; Wang W; Zhao D
    Biochem Biophys Res Commun; 2014 Mar; 445(2):282-8. PubMed ID: 24491533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Li L; Sapkota M; Kim SW; Soh Y
    Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL.
    Park CK; Lee Y; Chang EJ; Lee MH; Yoon JH; Ryu JH; Kim HH
    Biochem Pharmacol; 2008 Jun; 75(11):2175-82. PubMed ID: 18433733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis.
    Van Phan T; Sul OJ; Ke K; Lee MH; Kim WK; Cho YS; Kim HJ; Kim SY; Chung HT; Choi HS
    Biochem Pharmacol; 2013 Apr; 85(8):1145-52. PubMed ID: 23380478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SIS3 suppresses osteoclastogenesis and ameliorates bone loss in ovariectomized mice by modulating Nox4-dependent reactive oxygen species.
    Pan W; Zheng L; Gao J; Ye L; Chen Z; Liu S; Pan B; Fang J; Lai H; Zhang Y; Ni K; Lou C; He D
    Biochem Pharmacol; 2022 Jan; 195():114846. PubMed ID: 34801525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice.
    Kimble RB; Bain S; Pacifici R
    J Bone Miner Res; 1997 Jun; 12(6):935-41. PubMed ID: 9169353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.